AA |
arachidonic acid |
CAD |
coronary artery disease |
CE |
cardioembolic |
CETP |
cholesterylester transfer protein |
COX |
cyclooxygenase |
cPLA2
|
cytosolic phospholipase A2
|
CVD |
cardiovascular disease |
CYP |
cytochrome P450 |
CysLT |
cysteinyl leukotriene |
DHA |
docosahexaenoic acid |
DPA |
docosapentaenoic acid |
EET |
epoxyeicosatrienoic acid |
END |
early neurological deterioration |
EPA |
eicosapentaenoic acid |
FA |
fatty acid |
FLAP |
5-LOX-activating protein |
HDL |
high-density lipoprotein |
HDL-C |
high-density lipoprotein cholesterol |
HETE |
hydroxyeicosatetraenoic acid |
HS |
hemorrhagic stroke |
IDL |
intermediate-density lipoprotein |
IS |
ischemic stroke |
LA |
linoleic acid |
LDL |
low-density lipoprotein |
LDL-C |
low-density lipoprotein cholesterol |
LOX |
lipoxygenase |
Lp(a) |
lipoprotein(a) |
LT |
leukotriene |
LX |
lipoxin |
LXA4ME |
lipoxin A4 methyl ester |
NMR |
nuclear magnetic resonance |
non-HDL-C |
non-high-density lipoprotein cholesterol |
NPD1 |
neuroprotectin D1 |
OGD |
oxygen-glucose deprivation |
PAF |
platelet-activating factor |
PCSK9 |
proprotein convertase subtilisin/kexin type-9 |
PG |
prostaglandin |
PGE2
|
prostaglandin E2
|
PGI2
|
prostaglandin I2, prostacyclin |
PUFA |
polyunsaturated fatty acid |
sEH |
soluble epoxide hydrolase |
TC |
total cholesterol |
TG |
triglyceride |
TXA2
|
thromboxane A2
|
VEGF |
vascular endothelial growth factor |
VLDL |
very low-density lipoprotein |